Curi Capital, LLC

Position in NEO — Neogenomics Inc

CIK 1332905 CHICAGO, IL

Position in NEO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,256,665

+$623,569 QoQ

Shares Held

86,132

+0.9% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#84

of 266 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Curi Capital, LLC holds $118,928,378 across 14 Diagnostics & Research names. NEO ranks #6 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	263,989	$50,284,624
2	IDXX	Idexx Laboratories Inc /De	59,496	$31,321,073
3	TMO	Thermo Fisher Scientific Inc.	53,292	$26,718,476
4	VCYT	Veracyte, Inc.	63,197	$3,711,559
5	NTRA	Natera, Inc.	7,481	$2,030,716
6	NEO	Neogenomics Inc This page	86,132	$1,256,665
7	ILMN	Illumina, Inc.	5,756	$1,012,077
8	GRAL	GRAIL, Inc.	9,006	$614,838

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,256,665	86,132	+0.9%	Shares	Other	2026-08-14
2026-03-31	$633,096	85,323	+2.4%	Shares	Other	2026-05-15
2025-12-31	$980,148	83,346	0.0%	Shares	Other	2026-02-17
2025-09-30	$643,431	83,346	+0.1%	Shares	Other	2025-11-13
2025-06-30	$608,630	83,260	-72.8%	Shares	Other	2025-08-14
2022-03-31	$3,715,530	305,805	+21.8%	Shares	Sole	2022-05-06
2021-12-31	$8,569,033	251,144	+3.1%	Shares	Sole	2022-01-26
2021-09-30	$11,748,321	243,539	+1.6%	Shares	Sole	2021-10-20
2021-06-30	$10,831,856	239,802	+24.7%	Shares	Sole	2021-08-13
2021-03-31	$9,274,870	192,305	+6.5%	Shares	Sole	2021-05-12
2020-12-31	$9,718,120	180,500	+2.3%	Shares	Sole	2021-02-11
2020-09-30	$6,510,900	176,495	-2.8%	Shares	Sole	2020-11-10
2020-06-30	$5,625,131	181,573	+16.7%	Shares	Sole	2020-08-05
2020-03-31	$4,296,612	155,618	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.